NEW YORK (GenomeWeb News) — BioMérieux said today that it has finalized its acquisition of in BioFire Diagnostics, giving it 100 percent ownership of the company.
BioMérieux, based in Marcy l'Etoile, France, first announced the agreement to purchase Salt Lake City, Utah-based BioFire in September.